Company intelligence / Profile preview

iResearch Atlanta

Decatur, Georgia, United States

Ownership: Private
Employees: ~59
Development stage: Other

Overview

iResearch Atlanta has conducted over 300 clinical trials in phases I-IV, enrolling more than 10,000 patients across a broad range of therapeutic areas including infectious disease, rare diseases, neurology, psychiatry, ophthalmology, and women's health. They have provided important community access to innovative medicines, including participation in COVID-19 studies and many pivotal and registrational industry-sponsored pharmaceutical trials.

Therapeutic areas: CardiovascularOphthalmologyEndocrinologyWomen's HealthNeurologyInfectious DiseasesRare DiseasesOtherPsychiatry
Modalities: Small moleculeBiologicMonoclonal antibodyDevice
Industry: Contract Research Organization

Beyond the preview

Go deeper on iResearch Atlanta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iResearch Atlanta.

Explore the full profile